FRCPath Haemostasis and Thrombosis Training and Update Online

Start date
29 March 2021
Course Type
Postgraduate, Continuing professional development
Fees
£400

This course will be online and sessions will be pre-recorded, they will be available from 29 March until 13 April 2021. There will also be 4 live 1 hour special online sessions at 17:30 on the 29th, 30th, 31st March and 1st April 2021.

Course Overview

This course will cover all aspects of Clinical and Laboratory Haemostasis and Thrombosis.

Maintenance of blood fluidity and patency of the vascular system is crucial for normal human physiology. The term ‘haemostasis’ refers to the normal response of the vessel to injury by forming a clot that serves to limit haemorrhage. Thrombosis is pathological clot formation that results when haemostasis is excessively activated in the absence of bleeding. Under normal physiological conditions there is a delicate equilibrium between the pathological states of hypercoagulability and hypocoagulability in the circulating blood. Both inherited and acquired disorders can result in either bleeding or thrombosis.  Thrombosis may occur in veins (venous thrombosis) or in arteries (arterial thrombosis). Venous thrombosis leads to congestion of the affected part of the body, while arterial thrombosis affects the blood supply and leads to damage of the tissue supplied by that artery (ischaemia and necrosis). Fragments of either an arterial or a venous thrombus can also break off as an embolus which can travel through the circulation and cause thromboembolism. Accurate clinical and laboratory diagnosis of these disorders is therefore not only critical for the prevention of significant morbidity and mortality but improves patient care and quality of life through prevention and treatment of future bleeding and thrombotic events. Our understanding of these physiological and pathophysiological conditions has also improved significantly over recent years. This has not only resulted in improved diagnosis but in the evolution of state of the art modern laboratory testing and therapies for both bleeding and thrombotic disorders.  As the subject is also rapidly and continually evolving, this course aims to continually give up to date training from established clinicians and scientists in the field.

  • Up-to-date physiology and pathophysiology of Haemostasis and Thrombosis
  • Comprehensive training in basic and advanced clinical and laboratory practice in Haemostasis and Thrombosis
  • Interactive state of the art Lectures from established clinicians and scientists in the field
  • FRCPath focussed
  • 2 live sessions on Case based data interpretation
  • 1 live session on COVID-19 and Haemostasis
  • 1 live Q&A session

Learning outcomes

  • Understand the physiology and pathophysiology of all aspects of Haemostasis and Thrombosis
  • Understand the clinical and laboratory diagnosis of inherited and acquired disorders of Haemostasis and Thrombosis 
  • Understand state of the art laboratory testing for diagnosing and monitoring treatment of Bleeding or Thrombotic Disorders
  • Understand state of the art treatment strategies for either Bleeding or Thrombotic Disorders.

Course Faculty

  • Shafina Ali, University Hospitals Birmingham
  • Raz Alikhan, Cardiff and Vale University Health Board
  • Charlotte Bradbury, University of Bristol
  • Alex Brill, University of Birmingham
  • Tina Dutt, Royal Liverpool Hospital
  • Keith Gomez, The Royal Free Hospital
  • David Gurney, University Hospitals Birmingham
  • Claire Harrison, Guy's and St Thomas'
  • Paul Harrison, University of Birmingham
  • Beverley Hunt, Guy's and St Thomas'
  • Ian Jennings, Sheffield
  • Steve Kitchen, Sheffield Teaching Hospitals
  • Will Lester, University Hospitals Birmingham
  • Gill Lowe, University Hospitals Birmingham
  • Peter MacCallum, Royal London
  • Gary Moore, Technoclone
  • Neil Morgan, University of Birmingham
  • Jayashree Motwani, Birmingham Women's and Children's Hospital
  • Sue Pavord, University of Oxford
  • Charles Percy, University Hospitals Birmingham
  • Susie Shapiro, Oxford University Hospitals
  • Jecko Thachil, Manchester Royal Infirmary
  • Mark Thomas, University of Birmingham
  • Henry Watson, NHS Grampian
  • Steve Watson, University of Birmingham

Who is the course for?

It is aimed at SpRs preparing for the part 2 FRCPath examination but is also suitable for clinicians, scientists and biomedical scientists in academia, the NHS, pharmaceutical and diagnostic companies wishing to gain intensive training in Haemostasis and Thrombosis.

Dates

The course will be available online from 29 March 2021.
There will also be 4 live 1 hour special online sessions at 17:30 on the 29th, 30th, 31st March and 1st April 2021. 

The course has approximately 30 hrs of content.

There are no assessments for the course.

Coronavirus (COVID-19) latest updates and FAQs for future students and offer-holders

Visit our FAQs

Fees

£400 per person

How To Apply

Register online with a credit/debit card via the University's online shop.

See how the University of Birmingham uses your data, view the Event attendee privacy notice.

The courses have minimum required attendance levels and the University reserves the right to cancel or postpone the course if the minimum required number of delegates has not been achieved for the course.

Culture and collections

Schools, institutes and departments

Services and facilities